These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8656666)

  • 21. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
    Schiffrin EL; Deng LY
    Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB; McCabe EJ; Hager WD; Schulman P
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
    Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
    Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of long-term beta-blockade on aortic root compliance in patients with Marfan syndrome.
    Rios AS; Silber EN; Bavishi N; Varga P; Burton BK; Clark WA; Denes P
    Am Heart J; 1999 Jun; 137(6):1057-61. PubMed ID: 10347331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic changes induced by cilazapril and atenolol during isometric stress in hypertensive patients.
    Pancera P; Arosio E; Priante F; Ribul M; De Marchi S; Lechi A
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):582-7. PubMed ID: 8314358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
    Leonetti G; Salvetti A
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-finding study of cilazapril (Inhibace) in patients with uncomplicated essential hypertension.
    Mroczek WJ; Klein J; Burris JF
    Clin Exp Hypertens A; 1991; 13(8):1415-32. PubMed ID: 1836986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of cilazapril in patients with essential hypertension.
    Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load.
    Poirier L; Pyzyk M; Provencher P; Lacourcière Y
    Am J Hypertens; 1991 Nov; 4(11):913-5. PubMed ID: 1838693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.
    Fletcher AE; Bulpitt CJ; Chase DM; Collins WC; Furberg CD; Goggin TK; Hewett AJ; Neiss AM
    Hypertension; 1992 Jun; 19(6 Pt 1):499-507. PubMed ID: 1534312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?
    Hirata K; Vlachopoulos C; Adji A; O'Rourke MF
    J Hypertens; 2005 Mar; 23(3):551-6. PubMed ID: 15716696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total arterial compliance in ambulatory hypertension during selective beta1-adrenergic receptor blockade and angiotensin-converting enzyme inhibition.
    Soma J; Aakhus S; Dahl K; Widerøe TE; Skjaerpe T
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):273-9. PubMed ID: 10028936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.